wu
polyomaviru
wupyv
novel
member
famili
polyomavirida
recent
detect
respiratori
tract
specimen
shotgun
sequenc
intriguingli
viral
genom
detect
respiratori
tract
specimen
children
respiratori
diseas
level
coinfect
establish
respiratori
virus
rang
moreov
studi
report
detect
wupyv
stool
serum
far
wupyv
infect
distinguish
viral
infect
mean
clinic
symptom
respiratori
tract
diseas
like
pneumonia
bronchiti
frequent
observ
patient
harbour
wupyv
detect
viremia
suggest
system
infect
howev
avail
data
prove
wupyv
human
pathogen
investig
necessari
respiratori
tract
infect
major
caus
hospit
admiss
infant
young
children
caus
broad
spectrum
establish
respiratori
tract
pathogen
particularli
virus
includ
respiratori
syncyti
viru
rsv
import
caus
sever
respiratori
tract
infect
young
children
influenza
virus
parainfluenza
virus
rhinovirus
coronavirus
adenovirus
studi
investig
entir
spectrum
establish
respiratori
tract
pathogen
rare
mostli
base
detect
pathogen
specif
antibodi
recent
year
studi
becam
avail
present
data
base
direct
detect
relev
infecti
agent
creer
cowork
identifi
least
one
potenti
pathogen
specimen
adult
suffer
lower
respiratori
tract
infect
lrti
contain
virus
contain
bacteria
still
leav
signific
diagnost
gap
fill
far
unidentifi
pathogen
microorgan
addit
agent
associ
respiratori
tract
infect
discov
recent
eg
human
metapneumoviru
hmpv
coronavirus
human
bocaviru
hbov
furthermor
herp
virus
may
contribut
fill
gap
assum
trigger
respiratori
tract
infect
unfortun
relev
studi
often
includ
pathogen
impact
human
metapneumoviru
relev
respiratori
tract
infect
well
establish
common
caus
upper
urti
lower
respiratori
tract
infect
lrti
children
elderli
immunocompromis
person
asymptomat
infect
seem
uncommon
hmpv
identifi
import
caus
bronchiol
young
children
novel
human
coronaviru
also
wide
accept
signific
respiratori
tract
pathogen
strong
associ
croup
shown
human
coronaviru
infect
observ
rather
infrequ
often
children
underli
diseas
sever
report
link
viru
pneumonia
bronchiol
human
bocaviru
hbov
increas
number
report
present
evid
associ
respiratori
tract
infect
howev
coinfect
establish
respiratori
tract
pathogen
frequent
recent
wu
polyomaviru
detect
respiratori
tract
specimen
first
polyomavirus
isol
name
jc
viru
bk
viru
virus
particular
famili
describ
first
time
wu
polyomaviru
ki
polyomaviru
merkel
cell
polyomaviru
wupyv
discov
shot
gun
sequenc
nasopharyng
aspir
threeyearsold
child
australia
suffer
pneumonia
investig
isol
total
nucleic
acid
nasopharyng
aspir
randomli
amplifi
fragment
clone
sequenc
obtain
clone
gain
shot
gun
sequenc
subject
autom
edit
databas
search
combin
technolog
led
identif
dnasequ
distant
sequenc
includ
sequenc
databas
relat
virus
famili
polyomavirida
thu
identif
novel
viru
belong
viral
famili
propos
exclus
base
molecular
data
far
system
vitro
vivo
propag
discov
neither
cell
line
anim
model
thu
koch
postul
could
fulfil
howev
molecular
data
form
reason
evid
propos
exist
novel
viru
wupyv
largescal
screen
base
technolog
one
use
discoveri
wupyv
may
power
tool
discov
new
infecti
agent
caus
respiratori
tract
diseas
particularli
regard
etiolog
gap
novel
viru
bp
dsdna
genom
gccontent
genom
contain
earli
code
region
encod
tantigen
late
code
region
encod
structur
protein
noncod
control
region
featur
typic
member
polyomaviru
famili
sequenc
ident
wupyv
amino
acid
level
wellknown
polyomavirus
rang
closest
rel
within
viru
famili
ki
polyomaviru
kipyv
sequenc
ident
describ
briefli
wupyv
thu
virus
group
new
subclass
polyomaviru
famili
howev
intern
committe
taxonomi
virus
ictv
recognis
wupyv
kipyv
yet
typic
member
famili
polyomavirida
form
small
nonenvelop
icosahedr
particl
nm
diamet
contain
supercoil
dsdna
genom
virion
made
pentam
structur
protein
pentam
bind
singl
copi
genom
attach
cellular
histon
evid
hint
viru
structur
wupyv
differ
polyomavirus
howev
wupyv
virion
display
electron
microscopi
thu
evid
precis
virion
structur
stage
base
genom
organis
two
subclass
polyomaviru
famili
postul
primatelik
group
mous
polyomalik
group
genom
member
subclass
divid
three
region
earli
code
region
encod
least
small
tantigen
larg
tantigen
bind
partner
rbprotein
late
code
region
encod
least
structur
protein
non
code
control
region
contain
viral
promot
origin
replic
earli
code
region
member
mous
polyomalik
group
addit
encod
medium
tantigen
wherea
late
code
region
member
primatelik
group
addit
encod
structur
protein
agnoprotein
apart
kipyv
jc
viru
bk
viru
closest
rel
wupyv
base
genom
organis
amino
acid
sequenc
earli
code
region
contain
splice
site
larg
tantigen
bind
domain
rbprotein
howev
wupyv
neither
encod
open
read
frame
middl
tantigen
agnoprotein
thu
wupyv
kipyv
provision
group
third
subclass
polyomaviru
famili
far
express
studi
conduct
wupyv
clarifi
whether
predict
open
read
frame
fact
express
viral
infect
target
interestingli
shown
hbov
predict
transcript
viru
necessarili
ident
transcript
detect
infect
cell
need
appropri
experiment
system
carri
express
studi
wupyv
character
polyomavirus
restrict
host
rang
bk
viru
jc
viru
closest
rel
wupyv
within
well
establish
member
viru
famili
humanspecif
suggest
host
rang
restrict
human
wupyv
infect
bkv
take
place
earli
childhood
year
old
children
seroposit
wupyv
infect
report
predominantli
children
year
age
suggest
strong
increas
seroposit
earli
childhood
viru
incub
period
wupyv
infect
unknown
respiratori
transmiss
suggest
jc
viru
bk
viru
although
diseas
relat
virus
involv
respiratori
tract
virus
extract
tonsil
tissu
viral
entri
rout
wupyv
complet
defin
could
defin
uptak
divid
cell
upper
respiratori
tract
oropharynx
case
would
like
mostli
children
risk
infect
due
grow
anabol
enhanc
involv
increas
cell
divis
altern
transmiss
may
occur
occasion
blood
transfus
organ
transplant
jc
viru
bk
viru
primari
infect
typic
subclin
link
mild
respiratori
ill
viral
dissemin
target
cell
occur
via
blood
site
lifelong
persist
epitheli
cell
kidney
bk
viru
lymphocyt
oligodendrocyt
well
epitheli
cell
kidney
jc
viru
immunocompet
bk
viru
carrier
show
viruria
show
shed
jc
viru
indic
viral
persist
termin
viral
reactiv
take
place
even
immunocompet
person
reactiv
assum
obvious
higher
extent
immunocompromis
individu
concordantli
relat
diseas
hemorrhag
cystiti
polyomaviru
nephropathi
bk
viru
progress
multifoc
leukencephalopathi
pml
jc
viru
predominantli
occur
person
reduc
immunocompet
wupyv
detect
respiratori
tract
specimen
respiratori
tract
assum
entri
site
viru
viru
detect
serum
indic
dissemin
occur
via
blood
far
site
persist
identifi
viru
detect
urin
thu
epitheli
cell
kidney
may
site
persist
wupyv
wupyv
made
respons
upper
lower
respiratori
tract
diseas
eg
bronchiol
croup
pneumonia
besid
nasopharyng
sampl
wupyv
could
also
detect
stool
sampl
even
patient
without
appar
clinic
respiratori
symptom
howev
determin
whether
wupyv
abl
replic
intestin
whether
accumul
oral
ingest
detect
wupyvinfect
sever
convent
pcr
format
well
realtim
pcr
protocol
develop
report
sensit
specif
antigen
antibodi
detect
format
report
far
cultur
system
known
time
diagnost
establish
respiratori
virus
base
broad
spectrum
avail
assay
aim
detect
virusspecif
antibodi
viral
protein
viral
nucleic
acid
acut
respiratori
tract
infect
commonli
short
incub
period
thu
antibodi
usual
present
begin
acut
phase
diseas
reason
detect
virusspecif
antibodi
complement
fixat
assay
enzym
link
immunosorb
assay
elisa
immunofluoresc
assay
ifa
avail
establish
respiratori
virus
inappropri
identif
etiolog
agent
caus
acut
respiratori
tract
infect
use
retrospect
epidemiolog
studi
direct
detect
viral
protein
viral
nucleic
acid
mode
choic
respiratori
viru
diagnost
viral
cell
cultur
repres
gold
standard
well
establish
respiratori
virus
slow
time
diagnost
less
time
consum
method
develop
compris
polymeras
chain
reaction
pcr
antigenspecif
elisa
antigenspecif
ifa
avail
respiratori
virus
fast
immunochromatograph
assay
sensit
specif
assay
vari
consider
pcr
display
highest
sensit
thu
restrict
pcr
format
detect
wupyv
bia
sensit
particularli
real
time
pcr
format
establish
track
record
sensit
detect
differenti
colonis
acut
infect
base
quantit
data
avail
autom
extract
nucleic
acid
permit
short
process
time
handl
larg
specimen
cohort
follow
discoveri
wupyv
australia
viru
detect
specimen
patient
respiratori
tract
diseas
contin
suggest
worldwid
distribut
far
wupyvdna
report
found
respiratori
tract
specimen
eg
nasopharyng
wash
tracheal
secret
bal
serum
faec
viru
could
detect
urin
uv
lightassoci
primari
malign
lymphoma
specimen
malign
diseas
investig
use
tracheal
secret
diagnost
shown
lead
underestim
rate
posit
specimen
compar
respiratori
materi
hbov
may
true
wupyv
data
avail
mainli
base
retrospect
studi
exclus
includ
symptomat
patient
detect
rate
respiratori
sampl
children
respiratori
diseas
vari
age
wupyv
infect
patient
rang
week
year
children
year
age
domin
infect
predominantli
detect
late
winter
spring
earli
summer
high
infect
rate
report
studi
popul
preselect
lack
immunocompet
hiv
posit
patient
detect
rate
respiratori
tract
specimen
blood
rate
coinfect
establish
respiratori
virus
lay
commonli
exceed
wupyv
detect
blood
possibl
indic
potenti
system
infect
le
cowork
present
evid
viral
persist
wattier
et
al
nosocomi
infect
wupyv
real
time
protocol
avail
allow
quantif
wupyv
quantif
viral
load
respiratori
tract
specimen
reveal
viral
titer
copiesml
low
medium
viral
load
domin
correl
viral
load
rate
coinfect
clinic
diagnos
observ
studi
includ
asymptomat
control
group
result
concord
reach
higher
detect
rate
control
group
higher
detect
rate
among
group
patient
respiratori
tract
diseas
prospect
studi
publish
recent
van
der
zalm
cowork
report
detect
wupyv
cohort
children
parent
contact
twice
week
period
novemb
april
ask
symptom
respiratori
tract
diseas
children
everi
two
week
respiratori
tract
specimen
collect
regardless
respiratori
symptom
specimen
children
symptom
wupyv
posit
specimen
healthi
children
indic
least
associ
wupyv
diseas
time
studi
avail
concern
therapeut
intervent
mainli
due
retrospect
natur
investig
causal
associ
wupyv
respiratori
diseas
shown
yet
need
therapeut
driven
associ
infect
diseas
studi
therapeut
intervent
expect
near
futur
bk
viru
associ
nephropathi
renal
transplant
patient
reduct
immunosuppress
therapi
recommend
possibl
case
progress
renal
dysfunct
fluoroquinolon
antibacteri
intraven
immunoglobulin
leflunomid
otherwis
refractori
casescidofovir
could
administ
jc
viru
caus
progress
multifoc
leukoencephalopathi
pml
specif
therapi
exist
hivposit
patient
haart
induc
improv
cellular
function
may
lead
least
temporari
improv
failur
treatment
approach
interferon
cytarabin
cidofovir
topotecan
document
discoveri
novel
respiratori
virus
potenti
diminish
diagnost
gap
respiratori
tract
infect
creer
cowork
omit
recent
identifi
respiratori
virus
studi
adult
report
diagnost
gap
share
specimen
children
neg
respiratori
pathogen
investig
hmpv
hbov
includ
studi
includ
novel
polyomavirus
herp
virus
thu
reduct
respiratori
tract
infect
unknown
origin
seem
reason
howev
substanti
gap
remain
leav
suffici
room
addit
respiratori
virus
discov
futur
far
final
proven
wupyv
real
caus
agent
respiratori
diseas
associ
viru
detect
previous
unexplain
respiratori
diseas
led
tempt
idea
wupyv
repres
new
etiolog
agent
particularli
case
respiratori
tract
pathogen
could
identifi
furthermor
associ
mous
pneumotrop
polyomaviru
intestin
pneumonia
signific
mortal
indic
polyomavirus
capac
respiratori
tract
pathogen
mani
studi
correl
detect
wupyv
incid
respiratori
symptom
argu
hypothesi
remain
difficult
prove
asymptomat
control
group
investig
suffici
addit
studi
includ
control
group
report
dissent
find
howev
two
studi
asymptomat
individu
display
lower
frequenc
viru
detect
compar
symptomat
patient
one
prospect
studi
avail
difficulti
prove
wupyv
respiratori
pathogen
may
due
fact
studi
avail
far
tri
correl
viru
respiratori
tract
diseas
gener
case
wupyv
caus
agent
particular
entiti
respiratori
tract
diseas
inclus
patient
display
kind
respiratori
diseas
may
bia
investig
focuss
singl
entiti
respiratori
diseas
prove
success
shown
caus
croup
associ
wupyv
viral
load
clinic
symptom
could
observ
far
coinfect
virus
describ
frequent
weaken
hypothesi
wupyv
respiratori
tract
pathogen
howev
collect
sampl
perform
mean
standard
protocol
among
variou
group
defin
time
point
onset
symptom
viral
load
decreas
acut
phase
infect
combin
longitudin
data
differ
time
point
one
analysi
may
bia
correl
viral
load
symptom
furthermor
detect
coinfect
exclud
pathogen
potenti
wupyv
earli
childhood
character
subsequ
episod
respiratori
infect
codetect
declin
pathogen
respons
last
episod
respiratori
diseas
pathogen
respons
present
acut
diseas
expect
determin
viral
load
kinet
would
allow
defin
clinic
impact
detect
microorgan
larg
tantigen
wupyv
contain
bind
site
rb
protein
thu
tumourigen
potenti
exclud
howev
associ
wupyv
diseas
particularli
tumour
diseas
suffici
investig
yet
taken
togeth
current
avail
data
neither
prove
deni
wupyv
respiratori
tract
pathogen
sever
scenario
may
describ
role
viru
best
wupyv
may
part
endogen
viral
flora
without
pathogen
potenti
opportunist
pathogen
pathogen
potenti
respiratori
tract
condit
still
defin
pacemak
secondari
infect
viral
pathogen
use
respiratori
tract
entri
rout
reach
final
target
cell
infect
cell
type
basi
diseas
relat
respiratori
tract
reach
final
conclus
power
control
studi
need
perform
prospect
howev
retrospect
analysi
ageand
timematch
control
popul
also
permit
conclus
data
collect
time
relat
respiratori
ill
ideal
prospect
studi
would
carri
multicenterdesign
includ
control
group
concentr
correl
wupyv
singl
entiti
respiratori
tract
diseas
criteria
inclus
specimen
compar
well
time
point
protocol
extract
specimen
known
suspect
respiratori
tract
pathogen
includ
followup
investig
perform
detect
method
choic
would
quantit
pcr
allow
discrimin
colonis
product
infect
addit
serolog
investig
includ
show
patient
seroconvert
respons
infect
studi
particip
evalu
enrol
besid
investig
respiratori
tract
diseas
cell
type
host
persist
viru
identifi
possibl
associ
tumour
diseas
investig
